CLINICAL_TRIALS
trial_result
· 2017-05-10
Clinical Trial Update: Neoadjuvant Pazopanib in Renal Cell Carcinoma [Phase 2]
Summary
Phase 2 trial evaluating neoadjuvant pazopanib for renal cell carcinoma has completed, with results posted on May 10, 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Renal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2017-05-10